| P50 | author | Daniel Antonio de Luis | Q51351179 |
| | Cristobal Jesus Morales Portillo | Q85483466 |
| P2093 | author name string | Antonio Ramírez de Arellano | |
| | Luis Lizán | |
| | Maria Giovanna Ferrario | |
| P2860 | cites work | Evaluating the cost-effectiveness of reduced mild hypoglycaemia in subjects with Type 1 diabetes treated with insulin detemir or NPH insulin in Denmark, Sweden, Finland and the Netherlands. | Q50554731 |
| | Cost-effectiveness of insulin detemir compared with NPH insulin in people with type 2 diabetes in Denmark, Finland, Norway, and Sweden. | Q50558242 |
| | Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD) | Q57412648 |
| | Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration | Q57412996 |
| | A 26-Week, Randomized, Parallel, Treat-to-Target Trial Comparing Insulin Detemir With NPH Insulin as Add-On Therapy to Oral Glucose-Lowering Drugs in Insulin-Naive People With Type 2 Diabetes | Q59311920 |
| | [What is an efficient health technology in Spain?] | Q74452012 |
| | Risk of cardiovascular disease and mortality in overweight and obese patients with type 2 diabetes: an observational study in 13,087 patients | Q79791438 |
| | Long-acting insulin analogues versus NPH human insulin in type 2 diabetes: a meta-analysis | Q81317578 |
| | Evaluation of the association between the EQ-5D (health-related utility) and body mass index (obesity) in hospital-treated people with Type 1 diabetes, Type 2 diabetes and with no diagnosed diabetes | Q81387279 |
| | Cost-effectiveness of insulin detemir compared with neutral protamine Hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in five European countries | Q84103603 |
| | Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin - from the UK health care cost perspective | Q87006980 |
| | An economic assessment of analogue basal-bolus insulin versus human basal-bolus insulin in subjects with type 1 diabetes in the UK | Q94522145 |
| | Standards of medical care in diabetes--2014 | Q28304435 |
| | Self-reported frequency and impact of hypoglycemic events in Spain. | Q33785123 |
| | Hypoglycaemia: the limiting factor in the glycaemic management of Type I and Type II diabetes | Q34756826 |
| | Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline | Q34905558 |
| | Long-term efficacy and safety of insulin detemir compared to Neutral Protamine Hagedorn insulin in patients with Type 1 diabetes using a treat-to-target basal-bolus regimen with insulin aspart at meals: a 2-year, randomized, controlled trial | Q36575356 |
| | Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society | Q36782795 |
| | A nine country study of the burden of non-severe nocturnal hypoglycaemic events on diabetes management and daily function | Q36872181 |
| | Increase of body weight during the first year of intensive insulin treatment in type 2 diabetes: systematic review and meta-analysis | Q37885450 |
| | Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications | Q38257168 |
| | Long-term cost-effectiveness of insulin detemir versus NPH insulin in type 2 diabetes in Sweden | Q39620628 |
| | Evaluating the cost-effectiveness of therapy conversion to insulin detemir in patients with type 2 diabetes in Germany: a modelling study of long-term clinical and cost outcomes | Q40079112 |
| | Comparison of once-daily insulin detemir with NPH insulin added to a regimen of oral antidiabetic drugs in poorly controlled type 2 diabetes | Q42605636 |
| | Evaluation of the long-term cost-effectiveness of insulin detemir compared with neutral protamine hagedorn insulin in patients with type 1 diabetes using a basal-bolus regimen in Sweden | Q42670982 |
| | Costs of managing severe hypoglycaemia in three European countries | Q43225734 |
| | Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study. | Q45829732 |
| | Insulin detemir improves glycaemic control with less hypoglycaemia and no weight gain in patients with type 2 diabetes who were insulin naive or treated with NPH or insulin glargine: clinical practice experience from a German subgroup of the PREDICT | Q47294978 |
| | The burden of hypoglycemia on healthcare utilization, costs, and quality of life among type 2 diabetes mellitus patients | Q47621323 |
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | type-1 diabetes | Q124407 |
| | insulin detemir | Q410965 |
| | type 2 diabetes | Q3025883 |
| P304 | page(s) | 593-610 | |
| P577 | publication date | 2015-11-20 | |
| P1433 | published in | Diabetes Therapy | Q26853803 |
| P1476 | title | Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain | |
| P478 | volume | 6 | |